SCHEMBL7118973

SCHEMBL7118973

CC(N)c1cnc[nH]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL801590 0.80
SCHEMBL7981771 0.76
SCHEMBL15683190 0.76
SCHEMBL6647445 0.76
SCHEMBL2006355 0.76
SCHEMBL20877696 0.76 HRH4 (0.55)
SCHEMBL25374785 0.76
SCHEMBL20307127 0.76
SCHEMBL3926222 0.76
SCHEMBL10858595 0.74 HRH3 (0.53)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4289833-A1 TYK2 INHIBITOR COMPOUND CONTAINING BICYCLIC RING CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD. (CN) 2023-12-13 EP disclosed
US-20210188814-A1 PYRIDAZINONE COMPOUNDS AND USES THEREOF CHARLES RIVER DISCOVERY RESEARCH SERVICES UK LIMITED (GB) 2021-06-24 US disclosed
WO-2021113669-A1 CANNABINOIDS AND USES THEREOF CORBUS PHARMACEUTICALS, INC. (US) 2021-06-10 WO disclosed
WO-2021113656-A1 CANNABINOIDS AND USES THEREOF CORBUS PHARMACEUTICALS, INC. (US) 2021-06-10 WO disclosed
US-10428095-B2 Compounds for treatment of complement mediated disorders ACHILLION PHARMACEUTICALS, INC. (US) 2019-10-01 US disclosed
US-20190031692-A1 COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERS ACHILLION PHARMACEUTICALS, INC. (US) 2019-01-31 US disclosed
EP-3380469-A1 BICYCLIC BET BROMODOMAIN INHIBITORS AND USES THEREOF CONVERGENE LLC (US) 2018-10-03 EP disclosed
WO-2017091661-A1 BICYCLIC BET BROMODOMAIN INHIBITORS AND USES THEREOF STROVEL JEFFREY WILLIAM (US) 2017-06-01 WO disclosed
WO-2016096589-A1 SYNTHETIC ENZYME MIMIC BASED ON A HISTIDINE SCAFFOLD UNILEVER PLC (GB) 2016-06-23 WO disclosed
WO-2016096590-A1 SYNTHETIC ENZYME MIMIC BASED ON A HISTIDINE SCAFFOLD UNILEVER PLC (GB) 2016-06-23 WO disclosed
WO-2003028739-A2 COMPOSITION FOR PREVENTING OR TREATING HYPERLIPIDEMIA OR HYPERGLYCEMIA COMPRISING A POLYMER OR ITS SALT FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-04-10 WO disclosed